Teva partners with Israeli institutes for early-stage drug research

Deutschland Nachrichten Nachrichten

Teva partners with Israeli institutes for early-stage drug research
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 Reuters
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 97%

Teva Pharmaceutical Industries on Monday signed research agreements with two lea...

FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference by its CEO, Kare Schultz, to discuss the company's 2019 outlooks in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen/File Photo

JERUSALEM - Teva Pharmaceutical Industries on Monday signed research agreements with two leading Israeli academic institutes, a move to boost its early-stage drug development with a focus on cancer treatments. The world’s largest generic drugmaker has been looking to expand its specialty portfolio and said it is seeking more than 400 new laboratories within Israeli academia.

A partnership with Tel Aviv University will focus on research and development in cancer and brain studies, while a collaboration with the Weizmann Institute of Science will try to identify antibodies for cancer treatment, Israel-based Teva said. “Teva is planning to carry out much more cutting-edge collaboration with researchers from leading universities and medical centers in Israel in the fields of oncology, immunology and brain studies - areas in which Israel has unique research capabilities,” said Steffen Nock, head of Teva’s innovative research team.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Reuters /  🏆 2. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Product Hunt Founder Ryan Hoover Raises $10 Million Second Fund For More Early-Stage ExperimentsProduct Hunt Founder Ryan Hoover Raises $10 Million Second Fund For More Early-Stage ExperimentsTwo years after launching the Weekend Fund, Product Hunt founder Ryan Hoover is back with a $10 million second fund to invest in -- and help create -- more early-stage entrepreneurs.
Weiterlesen »

Many stem cell clinics promise unapproved treatments: How to stay safeMany stem cell clinics promise unapproved treatments: How to stay safeStem cells hold a lot of promise, but much more research is needed.
Weiterlesen »

SpaceX's Starlink satellites are already messing with astronomical research but there are thousands more plannedSpaceX's Starlink satellites are already messing with astronomical research but there are thousands more plannedAstronomers warned that SpaceX's Starlink satellites could majorly jeopardise astronomical research.
Weiterlesen »

U.S. Mayo Clinic partners with Abu Dhabi to operate hospitalU.S. Mayo Clinic partners with Abu Dhabi to operate hospitalAbu Dhabi has partnered with U.S. non-profit organization Mayo Clinic in a joint...
Weiterlesen »

Merkel ally calls for better Franco-German ties after NATO rowMerkel ally calls for better Franco-German ties after NATO rowGermany and France must bury their differences and pursue a constructive partner...
Weiterlesen »



Render Time: 2025-03-09 23:56:53